The recent FDA approval of momelotinib in MF amp implications for clinical practice

>> YOUR LINK HERE: ___ http://youtube.com/watch?v=RpIepbX7sN4

Jean-Jacques Kiladjian, MD, PhD, Saint-Louis Hospital & Paris Diderot University, Paris, France, shares insights into the recent FDA approval of momelotinib ...

Speaker: Jean-Jacques Kiladjian, Institution: Saint-Louis Hospital & Paris Diderot University, Event: General Updates, Format: Interview, Subject: Myeloproliferative Neoplasms, Field: Treatment, Field: Trial Updates, Field: Perspectives, Medicines: Momelotinib, Medicines: Fedratinib, Medicines: Ruxolitinib, Medicines: Pacritinib, anemia, JAK inhibitors, Subject: Myelofibrosis
#############################